Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 12/20 | 0.51 |
| ▸ | CDC25B | P30305 | 11/20 | 0.51 |
| ▸ | EBP | Q15125 | 4/20 | 0.41 |
| ▸ | ACLY | P53396 | 2/20 | 0.41 |
| ▸ | ACACA | Q13085 | 2/20 | 0.41 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.36 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1050397 | 0.85 | ACLY (0.48) | CDC25ACDC25BEBPACLYACACA | |
| SCHEMBL300737 | 0.85 | ACLY (0.48) | CDC25ACDC25BEBPACLYACACA | |
| SCHEMBL14116734 | 0.81 | CDC25A (0.54) | CDC25ACDC25BEBP | |
| SCHEMBL14034589 | 0.81 | CDC25A (0.54) | CDC25ACDC25BEBP | |
| SCHEMBL29934951 | 0.81 | CDC25A (0.59) | CDC25ACDC25BEBPACLYACACA | |
| SCHEMBL2450675 | 0.80 | CDC25A (0.46) | CDC25ACDC25BEBPACLYACACA | |
| SCHEMBL2450676 | 0.80 | CDC25A (0.46) | CDC25ACDC25BEBPACLYACACA | |
| SCHEMBL2453402 | 0.76 | CDC25A (0.40) | CDC25ACDC25BEBPHSD11B1 | |
| SCHEMBL2453399 | 0.76 | CDC25A (0.40) | CDC25ACDC25BEBPHSD11B1 | |
| SCHEMBL3285804 | 0.73 | ACLY (0.61) | EBPACLYACACAHSD11B1HSD11B2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080206161-A1 | QUIESCENT FOAMABLE COMPOSITIONS, STEROIDS, KITS AND USES THEREOF | FOAMIX PHARMACEUTICALS LTD. (IL) | 2008-08-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080206161-A1 | QUIESCENT FOAMABLE COMPOSITIONS, STEROIDS, KITS AND USES THEREOF | NR5A1, CYP17A1, LIPA | CDC25A 674/4885CDC25B 1342/4885EBP 48/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.